clofibric acid has been researched along with ethacrynic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Balagué, CE; de Duffard, AM; de Ruiz, CS; Nader-Macías, ME; Rey, R | 1 |
| Balagué, C; De Duffard, AM; De Ruiz, CS; Duffard, R; Nader-Macías, ME; Rey, R; Stürtz, N | 1 |
1 review(s) available for clofibric acid and ethacrynic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for clofibric acid and ethacrynic acid
| Article | Year |
|---|---|
Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Adhesion; Clofibric Acid; Escherichia coli; Escherichia coli Infections; Ethacrynic Acid; Female; Fimbriae, Bacterial; Kidney; Membrane Proteins; Mice; Mice, Inbred BALB C; Microscopy, Electron; Pyelonephritis; Urinary Tract Infections; Urine | 2004 |
Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Clofibric Acid; Disease Models, Animal; Diuretics; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Ethacrynic Acid; Female; Hypolipidemic Agents; Kidney; Mice; Microbial Sensitivity Tests; Urinary Tract Infections | 2006 |